Original Article
Original Article
/ VOLUME 3, ISSUE 2, AUGUST 2021
Asiye Bahar Kaçmaz and others
The SARS-CoV-2 infection has influenced the whole world and every day, both the number of cases and deaths related to the COVID-19 pandemic continue to rise. Eighty-one percent of COVID-19 cases are mild, 14% are serious and 5% are critical. Although the overall mortality rate was 2.3%, mortality (...) Read More
Original Article
/ VOLUME 3, ISSUE 2, AUGUST 2021
Mahir Kapmaz and others
The clinical findings of SARS-CoV-2 infection are heterogeneous, and the duration of viral RNA shedding varies on the age of the patient, severity of the disease, and type of the sample. For that reason, a comprehensive analysis of the dynamics of viral shedding is critical for (...) Read More
Original Article
/ VOLUME 3, ISSUE 2, AUGUST 2021
Çiğdem Erol and others
SARS-CoV-2 is transmitted via the inhalation of infected droplets or through direct contact with contaminated surfaces. Aerosol-generating procedures can also lead to airborne transmission. Healthcare workers (HCWs) are at higher risks for infections than the general (...) Read More
Original Article
/ VOLUME 3, ISSUE 1, APRIL 2021
Serap Şimşek-Yavuz and others
Infective endocarditis (IE), among the most common life-threatening infection, is a serious disease causing substantial morbidity and mortality. Determining at-risk patients and following them up closely with appropriate interventions are necessary to decrease complications and mortality. Treatment response to infective endocarditis is followed up with the combination of relief of symptoms, blood cultures, echocardiographic investigations and laboratory tests. A simple and widely available test Read More
Original Article
/ VOLUME 3, ISSUE 1, APRIL 2021
Şiran Keske and others
Healthcare-associated infections (HAI) is an increasing global problem all over the world. Multidrug-resistant (MDR) pathogens, including carbapenem-resistant Gram-negative Enterobacterales, Pseudomonas spp. and Acinetobacter spp. have become common causes of HAI, such as central line-associated bloodstream infections (BSIs), catheter-associated urinary tract infections (UTIs), surgical site infections (SSIs) and ventilatory associated pneumonia (VAPs). These infections increase not only mortality but also healthcare Read More
Original Article
/ VOLUME 3, ISSUE 1, APRIL 2021
Aral Sürmeli and others
Introduction The novel coronavirus (SARS-CoV-2) started in December 2019 in China, has infected over 4.2 million people worldwide, resulting in a death toll of 290 000 as of 13 May 2020 (1). It causes a multi-systemic infection named Coronavirus Disease 2019 (COVID-19). The symptoms reported are Read More
Original Article
/ VOLUME 3, ISSUE 1, APRIL 2021
Oğuz Evlice and others
Introduction More than a year has passed since the beginning of the COVID-19 pandemic, and we are learning more about the long-term effects of the disease. While many patients recover completely, some continue to experience fatigue, dyspnea, cough, joint pain, and chest pain for weeks or even months (1).The UK National Institute for Health and […] Read More
Original Article
/ VOLUME 2, ISSUE 3, DECEMBER 2020
Mehtap Aydın and others
Surgical site infections (SSI) are defined as infections that occur up to 30 days or one year after surgery in patients with implants, affecting the incision or deep tissue at the surgery site. They account for 20% of all healthcare-associated infections (HAI) in hospitalized patients. Patients with SSI are hospitalised additionally 7-11 days postoperatively. Read More
Original Article
/ VOLUME 2, ISSUE 3, DECEMBER 2020
Ezgi Oralkan and others
The increase of colistin resistance in Acinetobacter baumannii is a great concern in various regions of the world such as Asia, Europe, and North and South America. Exposure to colistin is considered the most significant factor for emerging of colistin resistance; however, details of the in vivo response Read More
Original Article
/ VOLUME 2, ISSUE 3, DECEMBER 2020
İlker Kayı and others
Cervical cancer is the fourth leading cause of all cancers among women globally, and 90% of all deaths occur in low- and middle-income countries. Sexual intercourse is the main route of transmission for HPV infection. The course of HPV infection differs according to the HPV type, immune status of the women, Read More
Original Article
/ VOLUME 2, ISSUE 3, DECEMBER 2020
Duygu Özkaya and others
Healthcare-associated infections (HAIs) are infections, which are not present at admission or might be in incubating, are acquired in the hospital. HAIs remain a major problem for they increase not only morbidity and mortality but also costs for health care systems. Read More
Original Article
/ VOLUME 2, ISSUE 3, DECEMBER 2020
Altan Gökgöz and others
Infectious Diseases and Clinical Microbiology (IDCM) physicians have pivotal role in responding to the coronavirus disease 2019 (COVID-19) pandemic. Their involvement ranges from managing cases and coordinating local responses to establishing timely and accurate diagnostic testing. Read More
Original Article
/ VOLUME 2, ISSUE 3, DECEMBER 2020
İbrahim Etem Dural and Yasemin Nadir
The first case of COVID-19 was reported on 10 March 2020 in Turkey. Various treatment options have been used in all countries because of the lack of proven treatment. Among these options, hydroxychloroquine (HQN) and azithromycin (AZ) combination is expected to treat Read More
Original Article
/ VOLUME 2, ISSUE 2, AUGUST 2020
Bahar Madran and others
A new coronavirus (SARS-CoV-2) appeared at the end of 2019 in China and spread widely throughout the world. The coronavirus disease 2019 (COVID-19) is a new respiratory disease, and its pandemic has affected more than seven million people all around the world. The first COVID-19 case in Turkey was detected on Read More
Original Article
/ VOLUME 2, ISSUE 2, AUGUST 2020
Zeynep Türe and others
In December 2019, Wuhan city, the capital of Hubei province in China, became the center of an outbreak of pneumonia of unknown cause. By Jan 7, 2020, Chinese scientists had isolated a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; previously known as 2019-nCoV), from these Read More
Original Article
/ VOLUME 2, ISSUE 2, AUGUST 2020
Vildan Avkan-Oğuz and others
Complicated intra-abdominal infection (cIAI) is defined as localized or diffuse peritonitis with the involvement of multiple intraperitoneal organs. Source control and appropriate empirical antibiotics are essentials of the treatment. There are few clinical and microbiologic studies regarding cIAI in Turkey. Empiric antibiotics were selected due to diagnoses; community-acquired IAI (CA-IAI) or healthcare-associated IAI. Guidelines published on this topic lack definitive criteria for CA-IAI. Read More
Original Article
/ VOLUME 2, ISSUE 2, AUGUST 2020
Özgür Can Eren and others
In 2019, more than 36 million people were estimated to be harboring HIV, and the epidemic caused 39 million deaths worldwide to date. New adult infections have been declined by 17% between 2007 and 2017 globally. Meanwhile, the incidence has an Read More
Original Article
/ VOLUME 2, ISSUE 1, APRIL 2020
Çiğdem Akalan Kuyumcu and others
Brucellosis is a zoonotic infectious disease caused by Gram-negative bacteria of the genus Brucella, which is transmitted from animals to humans by direct and indirect pathways. Brucellosis can be confused with various infectious and non-infectious diseases because of its nonspecific clinical signs and symptoms such as fever, sweating, Read More
Original Article
/ VOLUME 2, ISSUE 1, APRIL 2020
Ahmet Özbilgin and others
Visceral Leishmaniasis (VL) is a widespread infectious disease of the reticuloendothelial system which is mostly caused by Leishmania infantum (L. infantum) and L. donovani in the Old World. The disease is endemic in many parts of the world, and estimated cases of VL have reached 300,000 globally with a high rate of HIV co-infection, and over Read More
Original Article
/ VOLUME 2, ISSUE 1, APRIL 2020
İrem Akdemir Kalkan and others
Influenza is a systemic infectious disease. Many groups, including patients with concomitant chronic heart and lung diseases, immunosuppressed individuals, people over 50 years old, and all health staff are considered at-risk groups for influenza. Pregnant women are particularly considered to be at a higher risk. Read More